Merck & Co.

Merck Supports The Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN)

Blog
At Merck, we aspire to improve the health and wellness of people worldwide, and to expand access to our medicines and vaccines. As part of our ongoing commitment to fighting neglected tropical diseases, Merck has announced a $500,000 grant to the World Health Organization’s Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN).
 

In Pursuit of Universal Health Care: Time to Take Public-Private Partnership to the Next Level

By Dr. Naveen Rao
Article
The buzz around public-private partnership (PPP) keeps getting louder. And yes – PPPs are everywhere, operating in virtually every industry sector around the world, including health.
 

Merck & Co., Inc., Kenilworth, N.J., USA Publishes 2016/2017 Corporate Responsibility Report

Article

Merck & Co., Inc., Kenilworth, N.J., USA recently issued its 2016/2017 Global Corporate Responsibility Report. The report provides an overview of the company’s corporate responsibility activities, progress and performance in the areas of Access to Health, Employees, Environmental Sustainability and Ethics & Transparency.

Merck & Co., Inc., Kenilworth, N.J., USA Publishes 2015/2016 Corporate Responsibility Report

Article

Merck & Co., Inc., Kenilworth, N.J., USA recently issued its 2015/2016 Global Corporate Responsibility Report. The report provides an overview of the company’s corporate responsibility activities, progress and performance in the areas of Access to Health, Environmental Sustainability, Employees and Ethics & Transparency.

Highlights from the 2015/2016 report include:

Achieving Triple Impact: Purposeful Engagement that Goes Beyond Checkbook Philanthropy for Shared Value

New workshop helps companies adopt global pro bono, innovation in corporate investment Berlin, Germany
Press Release

SEPTEMBER 22, 2014, Washington, D.C., Berlin, Germany /3BL Media/  On September 25, SAPPYXERA Global, and, UPJ host Achieving Triple Impact, the first workshop of its kind to bring together European corporations in Berlin, Germany to explore how investment in global pro bono programs can achieve triple impact for companies, their employees, and communities worldwide

PYXERA Global Announces Annual 5th International Corporate Volunteerism Conference

Multinational corporations address global pro bono and emerging market growth on April 8th
Press Release

WASHINGTON, March 13, 2014 /3BL Media/ – PYXERA Global proudly announces the event line-up for the Annual International Corporate Volunteerism (ICV) Conference on April 8th, 2014 in Washington, D.C.

Subscribe to Merck & Co.